Cyclobenzaprine Hydrochloride
Product Images NDC 0440-1350

2 FDA label images from Liberty Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0440-1350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Liberty Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine Hydrochloride Structural Formula (Cyclobenzaprine For Watson 1)

Cyclobenzaprine Hydrochloride Structural Formula (Cyclobenzaprine For Watson 1)
Chemical structure diagram of Cyclobenzaprine Hydrochloride showing its molecular framework including bicyclic rings and side chain with dimethylamine group.*
FDA Label Image

Image Label (Cyclobenzaprine For Watson 2)

Image Label (Cyclobenzaprine For Watson 2)
Cyclobenzaprine Hydrochloride 10 mg film-coated tablets label from Liberty Pharmaceuticals, Inc. The package contains 9 tablets and is marked RX only. It includes a lot number and expiration date area, with the product manufactured by Watson Laboratories, Inc. The label also states it is packaged by Aidarex Pharmaceuticals LLC in Corona, CA and includes cautionary storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.